Journal
TRENDS IN PHARMACOLOGICAL SCIENCES
Volume 23, Issue 1, Pages 4-7Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/S0165-6147(00)01929-5
Keywords
-
Categories
Ask authors/readers for more resources
(-)-Stepholidine (SPD), an active ingredient of the Chinese herb Stephania, is a dopamine D1 receptor agonist and a D2 receptor antagonist. The dual actions of SPD have been demonstrated in both cortical and subcortical structures, including the medial prefrontal cortex (mPFC), nucleus accumbens, ventral tegmental area and basal ganglia dopamine systems. D1 receptor dysfunction in the mPFC and D2 receptor hyperactivity in the subcortex are thought to occur in sufferers of schizophrenia. Thus, the dual effects of SPD suggest that this compound might represent a novel antipsychotic agent.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available